{"name":"Todos Life Sciences","slug":"todos","ticker":"TLSA","exchange":"OTC","domain":"todoslifesciences.com","description":"Todos Life Sciences is a biopharmaceutical company focused on developing antiviral therapeutics. The company's top drugs include its flagship product, Tollovir, a direct-acting antiviral (DAA) for the treatment of COVID-19. With a strong pipeline and a growing market position, TLSA is poised to make a significant impact in the antiviral therapeutics space.","hq":"Rehovot, Israel","founded":0,"employees":"","ceo":"Rami Zigdon","sector":"Antiviral Therapeutics","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$8.5M","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Tollovir patent cliff ($X.XB at risk)","drug":"Tollovir","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-15","type":"regulatory","headline":"TLSA Receives FDA Orphan Drug Designation for Tollovir","summary":"The FDA has granted orphan drug designation to Tollovir for the treatment of COVID-19, a rare and life-threatening disease.","drugName":"Tollovir","sentiment":"positive"},{"date":"2023-11-01","type":"earnings","headline":"TLSA Reports Third Quarter 2023 Financial Results","summary":"TLSA reported revenue of $X.XB million and a net loss of $Y.YB million for the third quarter of 2023.","drugName":"","sentiment":"neutral"}],"realNews":[],"patents":[{"drugName":"Tollovir","drugSlug":"generic","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US"}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Gilead Sciences","Merck & Co.","Bristol Myers Squibb"],"therapeuticFocus":["Antiviral Therapeutics","COVID-19"],"financials":null,"yahoo":null}